Skip to main content
TACTILE SYSTEMS TECHNOLOGY INC logo

TACTILE SYSTEMS TECHNOLOGY INC — Investor Relations & Filings

Ticker · TCMD ISIN · US87357P1003 LEI · 54930069VDTITHOTKJ98 US Manufacturing
Open in API
Filings indexed 820 across all filing types
Latest filing 2017-01-09 Earnings Release
Country US United States of America
Listing US TCMD

About TACTILE SYSTEMS TECHNOLOGY INC

https://www.tactilemedical.com/

Tactile Systems Technology, Inc., operating as Tactile Medical, is a medical technology company that develops and provides at-home therapy devices for underserved chronic diseases. Its primary focus is on treating lymphedema, lipedema, and chronic venous insufficiency with advanced pneumatic compression devices, including the Flexitouch Plus and Nimbl systems. These products are designed to help patients manage chronic swelling and improve their quality of life. The company also offers respiratory solutions through its AffloVest, a mobile high-frequency chest wall oscillation (HFCWO) therapy device designed for airway clearance in patients with chronic respiratory conditions or neuromuscular disorders. Tactile Medical's solutions are developed to provide clinically effective and convenient treatments for use outside of a clinical setting.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated January 9, 2017, reporting preliminary estimated revenue for 2016 and the most recently completed fiscal quarter. It includes a press release as an exhibit. The content is a current report disclosing financial results but not a full financial report like an annual or quarterly report. The document is relatively short (3266 characters) and primarily serves as an announcement of financial results rather than containing detailed financial statements or analysis. Therefore, it fits the category of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only.
2017-01-09 English
FORM 4
Director's Dealing
2017-01-04 English
FORM 4
Director's Dealing
2017-01-04 English
FORM 4
Director's Dealing
2016-12-15 English
RW
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the SEC requesting withdrawal of a Registration Statement on Form S-1. It explicitly states that the Registration Statement is not effective and no securities have been sold. The letter is a formal regulatory communication about the withdrawal of a filing, not a financial report or detailed filing itself. The document length is short (1944 characters) and it is a regulatory notice rather than a report or announcement of financial results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory communications that do not fit other specific categories.
2016-12-13 English
S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes details about the offering, underwriting, risk factors, use of proceeds, capitalization, and other information typical of a registration prospectus. This is not an annual report, earnings release, or any other financial report but a capital markets filing related to the company's initial or secondary public offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or a brief notice, confirming it is the actual registration statement/prospectus filing.
2016-11-22 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.